Cardiac Biotech Solutions Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CBSC research report →
Companycardiacbiotech.com
Cardiac Biotech Solutions Inc. , through its international subsidiaries, provides innovative products and services in the ambulatory non-invasive cardiac monitoring space. Our FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improved compliance for patients at risk of abnormal heart rhythms as well as more accurate information for physicians.
- CEO
- Charles K. Martin
- IPO
- 2016
- Employees
- 5
- HQ
- Las Vegas, CA, US
Price Chart
Valuation
- Market Cap
- $3.60M
- P/E
- -4.40
- P/S
- 30.25
- P/B
- -2.37
- EV/EBITDA
- -3.10
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 37.84%
- Op Margin
- -1147.66%
- Net Margin
- -1010.20%
- ROE
- 58.18%
- ROIC
- 119.79%
Growth & Income
- Revenue
- $41.40K · -69.35%
- Net Income
- $-1,680,696 · -3.09%
- EPS
- $-0.01 · 9.40%
- Op Income
- $-1,327,787
- FCF YoY
- 0.00%
Performance & Tape
- 52W High
- $0.08
- 52W Low
- $0.02
- 50D MA
- $0.04
- 200D MA
- $0.04
- Beta
- 1.86
- Avg Volume
- 19.70K
Get TickerSpark's AI analysis on CBSC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our CBSC Coverage
We haven't published any research on CBSC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CBSC Report →